Mylan Prepares To Launch Canada's First Trastuzumab Within Weeks

 
• By Aidan Fry

By the end of June, Mylan expects to have launched in Canada the Ogivri trastuzumab 150mg and 440mg vials for which it has just received regulatory approval.

Canada_Balloons
Mylan expects to first-to-market with biosimilar trastuzumab in Canada • Source: Shutterstock

More from Biosimilars

More from Products